Nifty

:

8083.80

Sensex

:

27590.95

-170.00 (-2.06%)
-674.36 (-2.39%)

Login

Nifty
Sensex

:
:

8083.80
27590.95

-170.00 (-2.06%)
-674.36 (-2.39%)

Pfizer Ltd.

Pharmaceuticals & Drugs

Rating :

86/99

BSE: 500680 | NSE: PFIZER

Watchlist

NSE BSE

4020.00

03-Apr-2020

Open
High
Low
Previous Close

3990.00
4119.00
3860.45
3966.35

Volume
Traded Value (lacs)
52 Week High
52 Week Low

26647
1069.33
4925.00
2792.25

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

18,383.73
35.66
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

16,471.89
0.56%
5.58

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
2.35
1.92

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
8.32
10.07

PAT CAGR (%)

10 Years
5 Years
3 Years

-
43.78
8.41

P:E (Median)

8 Years
5 Years
3 Years

31.29
33.98
32.60

P:BV (Average)

8 Years
5 Years
3 Years

5.70
5.70
5.70

EV:EBITDA (Average)

8 Years
5 Years
3 Years

14.40
17.19
17.06

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 19 Dec 18 Var% Sep 19 Sep 18 Var% Jun 19 Jun 18 Var% Mar 19 Mar 18 Var%
Net Sales 538.18 513.79 4.75% 567.06 519.74 9.10% 544.40 512.31 6.26% 535.66 519.95 3.02%
Expenses 404.74 359.46 12.60% 402.88 389.97 3.31% 378.17 382.20 -1.05% 384.67 381.49 0.83%
EBITDA 133.44 154.33 -13.54% 164.18 129.77 26.52% 166.23 130.11 27.76% 150.99 138.46 9.05%
EBIDTM 24.79% 30.04% 28.95% 24.97% 30.53% 25.40% 28.19% 26.63%
Other Income 58.22 64.35 -9.53% 44.75 37.06 20.75% 35.83 30.53 17.36% 35.45 31.23 13.51%
Interest 2.46 0.29 748.28% 2.62 0.22 1,090.91% 2.15 0.17 1,164.71% 0.61 -0.12 -
Depreciation 24.70 17.77 39.00% 25.13 17.73 41.74% 25.00 18.28 36.76% 17.61 17.27 1.97%
PBT 164.50 200.62 -18.00% 181.18 148.88 21.70% 174.91 142.19 23.01% 168.22 152.54 10.28%
Tax 25.44 68.68 -62.96% 26.93 53.08 -49.27% 62.10 50.35 23.34% 58.75 48.03 22.32%
PAT 139.06 131.94 5.40% 154.25 95.80 61.01% 112.81 91.84 22.83% 109.47 104.51 4.75%
PATM 25.84% 25.68% 27.20% 18.43% 20.72% 17.93% 20.44% 20.10%
EPS 30.40 28.84 5.41% 33.72 20.94 61.03% 24.66 20.07 22.87% 23.93 22.84 4.77%

Description Dec 19 Dec 18 Var% Sep 19 Sep 18 Var% Jun 19 Jun 18 Var% Mar 19 Mar 18 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Nov 09
Net Sales 2,185.30 2,081.50 1,968.51 1,966.26 2,012.34 1,853.32 1,111.81 1,048.84 1,093.29 1,252.45 799.73 Net Sales Growth 5.79% 5.74% 0.11% -2.29% 8.58% 66.69% 6.00% -4.07% -12.71% 56.61% Cost Of Goods Sold 785.04 678.48 677.55 711.67 698.85 649.77 305.51 270.02 290.09 312.64 233.46 Gross Profit 1,400.26 1,403.02 1,290.96 1,254.59 1,313.49 1,203.55 806.30 778.83 803.19 939.81 566.27 GP Margin 64.08% 67.40% 65.58% 63.81% 65.27% 64.94% 72.52% 74.26% 73.47% 75.04% 70.81% Total Expenditure 1,570.46 1,515.87 1,467.87 1,616.13 1,579.46 1,473.98 872.54 864.68 896.48 983.24 643.80 Power & Fuel Cost - 11.45 12.34 10.34 10.43 10.40 8.62 8.61 9.07 9.14 8.51 % Of Sales - 0.55% 0.63% 0.53% 0.52% 0.56% 0.78% 0.82% 0.83% 0.73% 1.06% Employee Cost - 323.84 314.29 303.89 277.34 236.36 191.77 211.12 192.82 226.99 125.58 % Of Sales - 15.56% 15.97% 15.46% 13.78% 12.75% 17.25% 20.13% 17.64% 18.12% 15.70% Manufacturing Exp. - 131.96 118.74 151.54 153.84 162.31 124.18 118.58 125.03 149.51 102.02 % Of Sales - 6.34% 6.03% 7.71% 7.64% 8.76% 11.17% 11.31% 11.44% 11.94% 12.76% General & Admin Exp. - 182.49 173.38 234.11 207.63 202.62 124.64 126.94 127.91 109.55 63.47 % Of Sales - 8.77% 8.81% 11.91% 10.32% 10.93% 11.21% 12.10% 11.70% 8.75% 7.94% Selling & Distn. Exp. - 152.83 143.35 152.82 168.00 156.82 87.83 100.10 122.93 113.34 73.53 % Of Sales - 7.34% 7.28% 7.77% 8.35% 8.46% 7.90% 9.54% 11.24% 9.05% 9.19% Miscellaneous Exp. - 34.82 28.22 51.76 63.38 55.71 29.98 29.32 28.62 62.08 73.53 % Of Sales - 1.67% 1.43% 2.63% 3.15% 3.01% 2.70% 2.80% 2.62% 4.96% 4.66% EBITDA 614.84 565.63 500.64 350.13 432.88 379.34 239.27 184.16 196.81 269.21 155.93 EBITDA Margin 28.14% 27.17% 25.43% 17.81% 21.51% 20.47% 21.52% 17.56% 18.00% 21.49% 19.50% Other Income 174.25 167.39 114.29 101.16 86.99 71.72 109.38 105.24 92.73 92.90 73.28 Interest 7.84 1.72 0.77 1.96 1.40 1.51 1.10 1.73 2.08 2.47 0.00 Depreciation 92.44 71.39 66.25 62.93 57.93 131.08 7.97 8.02 9.56 12.00 8.29 PBT 688.81 659.91 547.91 386.40 460.54 318.46 339.58 279.65 277.90 347.65 220.93 Tax 173.22 230.86 187.84 180.05 165.44 137.68 118.73 190.57 92.92 118.28 73.13 Tax Rate 25.15% 34.98% 34.28% 34.84% 35.17% 66.36% 34.96% 27.47% 33.48% 34.32% 34.82% PAT 515.59 429.05 360.07 336.78 304.98 69.82 220.86 503.20 184.61 226.34 136.88 PAT before Minority Interest 515.59 429.05 360.07 336.78 304.98 69.82 220.86 503.20 184.61 226.34 136.88 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 23.59% 20.61% 18.29% 17.13% 15.16% 3.77% 19.86% 47.98% 16.89% 18.07% 17.12% PAT Growth 21.58% 19.16% 6.92% 10.43% 336.81% -68.39% -56.11% 172.57% -18.44% 65.36% Unadjusted EPS 112.71 93.78 78.70 73.61 66.66 15.26 74.01 168.63 61.87 75.85 45.87

Description TTM Nov 08 Nov 07 Nov 06 Nov 05
Net Sales - 736.83 736.57 736.33 674.84 Net Sales Growth - 0.04% 0.03% 9.11% Cost Of Goods Sold - 195.94 190.88 186.99 189.67 Gross Profit - 540.89 545.69 549.34 485.17 GP Margin - 73.41% 74.09% 74.61% 71.89% Total Expenditure - 585.58 580.08 570.64 558.84 Power & Fuel Cost - 7.17 7.94 7.50 7.96 % Of Sales - 0.97% 1.08% 1.02% 1.18% Employee Cost - 98.43 98.71 100.37 98.57 % Of Sales - 13.36% 13.40% 13.63% 14.61% Manufacturing Exp. - 92.14 85.84 85.45 80.87 % Of Sales - 12.50% 11.65% 11.60% 11.98% General & Admin Exp. - 49.05 48.30 45.81 45.04 % Of Sales - 6.66% 6.56% 6.22% 6.67% Selling & Distn. Exp. - 99.87 106.89 103.95 96.59 % Of Sales - 13.55% 14.51% 14.12% 14.31% Miscellaneous Exp. - 42.98 41.51 40.57 40.15 % Of Sales - 5.83% 5.64% 5.51% 5.95% EBITDA - 151.25 156.49 165.69 116.00 EBITDA Margin - 20.53% 21.25% 22.50% 17.19% Other Income - 71.10 321.80 33.47 33.24 Interest - 0.00 0.02 0.07 0.16 Depreciation - 11.12 9.58 13.07 13.85 PBT - 211.22 468.69 186.01 135.23 Tax - 119.56 111.34 56.31 41.13 Tax Rate - 28.53% 24.67% 34.62% 36.77% PAT - 299.57 340.00 106.33 70.73 PAT before Minority Interest - 299.57 340.00 106.33 70.73 Minority Interest - 0.00 0.00 0.00 0.00 PAT Margin - 40.66% 46.16% 14.44% 10.48% PAT Growth - -11.89% 219.76% 50.33% Unadjusted EPS - 100.39 113.94 35.63 23.70

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Nov 09
Shareholder's Funds 3,011.34 2,683.20 2,418.88 2,163.50 1,973.01 658.41 1,694.42 1,304.70 1,163.45 994.33 Share Capital 45.75 45.75 45.75 45.75 45.75 29.84 29.84 29.84 29.84 29.84 Total Reserves 2,965.59 2,637.45 2,373.13 2,117.75 1,927.26 628.57 1,664.58 1,274.85 1,133.60 964.49 Non-Current Liabilities 36.96 52.32 62.41 66.14 -34.97 -19.30 -25.71 -11.26 -0.96 -27.50 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 2.50 2.50 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 34.73 37.74 44.85 35.30 29.56 14.79 14.07 25.83 28.20 0.00 Current Liabilities 891.69 954.44 779.67 658.41 608.52 303.38 350.91 251.04 188.23 1,060.82 Trade Payables 435.92 495.63 388.00 337.92 334.20 159.93 150.59 136.04 98.03 116.25 Other Current Liabilities 294.19 302.29 241.36 181.52 80.59 54.68 39.56 35.64 42.78 16.65 Short Term Borrowings 2.50 2.50 2.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 159.08 154.02 147.81 138.97 193.72 88.76 160.76 79.36 47.42 927.93 Total Liabilities 3,939.99 3,689.96 3,260.96 2,888.05 2,546.56 942.49 2,019.62 1,544.48 1,350.72 2,027.65 Net Block 853.86 916.60 867.08 924.86 944.34 20.02 25.57 31.49 35.89 92.49 Gross Block 1,100.27 1,094.86 983.27 980.63 1,288.60 114.83 117.27 118.00 117.69 187.81 Accumulated Depreciation 246.41 178.26 116.19 55.77 344.26 94.81 91.71 86.51 81.81 95.32 Non Current Assets 1,223.32 1,273.24 1,209.65 1,255.58 1,294.53 256.54 215.24 213.67 179.20 93.79 Capital Work in Progress 0.00 1.04 15.35 3.27 12.56 3.16 0.37 0.38 1.64 0.80 Non Current Investment 32.33 33.72 35.11 36.51 42.66 44.49 45.99 47.50 48.95 0.50 Long Term Loans & Adv. 224.23 236.25 226.29 225.71 294.97 188.87 143.31 134.31 92.72 0.00 Other Non Current Assets 112.90 85.63 65.82 65.23 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 2,716.67 2,416.72 2,051.31 1,632.47 1,252.02 685.95 1,804.39 1,330.80 1,171.51 1,933.86 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.05 0.00 0.00 Inventories 386.66 297.06 321.90 360.68 387.90 151.50 165.15 183.24 159.32 113.37 Sundry Debtors 171.66 154.80 110.32 142.30 160.02 173.39 142.09 141.78 100.17 64.39 Cash & Bank 1,914.34 1,771.86 1,523.09 1,024.65 609.29 307.79 1,432.94 866.27 578.46 527.40 Other Current Assets 244.01 147.04 43.52 47.65 94.82 53.28 64.21 139.47 333.56 1,228.70 Short Term Loans & Adv. 23.02 45.96 52.48 57.20 80.52 47.17 43.23 129.83 325.23 1,223.88 Net Current Assets 1,824.98 1,462.28 1,271.64 974.06 643.51 382.58 1,453.47 1,079.77 983.28 873.04 Total Assets 3,939.99 3,689.96 3,260.96 2,888.05 2,546.55 942.49 2,019.63 1,544.47 1,350.71 2,027.65

Description Nov 08 Nov 07 Nov 06 Nov 05
Shareholder's Funds 901.09 649.72 439.76 375.95 Share Capital 29.84 29.84 29.84 29.84 Total Reserves 871.25 619.88 409.91 346.11 Non-Current Liabilities -22.67 -12.98 -14.36 -9.03 Secured Loans 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 Current Liabilities 926.36 820.65 696.33 623.95 Trade Payables 108.18 92.43 137.62 120.16 Other Current Liabilities 14.50 14.17 8.14 16.26 Short Term Borrowings 0.00 0.00 0.00 0.00 Short Term Provisions 803.68 714.05 550.57 487.53 Total Liabilities 1,804.78 1,457.39 1,121.73 990.87 Net Block 50.76 60.16 69.96 75.56 Gross Block 139.90 141.61 168.14 170.15 Accumulated Depreciation 89.14 81.45 98.19 94.59 Non Current Assets 83.56 70.91 71.56 77.71 Capital Work in Progress 32.30 10.24 1.60 2.14 Non Current Investment 0.50 0.50 0.00 0.00 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 Current Assets 1,721.22 1,383.55 1,036.82 876.46 Current Investments 0.00 0.00 0.00 0.00 Inventories 124.99 95.85 99.31 90.71 Sundry Debtors 60.31 61.69 70.10 83.54 Cash & Bank 543.65 479.91 306.94 210.15 Other Current Assets 992.26 8.17 4.22 2.14 Short Term Loans & Adv. 977.77 737.92 556.25 489.92 Net Current Assets 794.86 562.90 340.50 252.52 Total Assets 1,804.78 1,457.39 1,121.72 990.87

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Nov 09
Cash From Operating Activity 97.81 331.80 328.82 345.48 113.47 132.45 -16.01 24.46 80.14 74.67 PBT 547.91 547.91 516.83 470.42 238.02 339.58 279.65 277.90 347.65 220.93 Adjustment -79.47 -32.98 -153.93 -19.53 60.89 -87.82 -84.49 -69.40 -65.23 -45.01 Changes in Working Capital -245.07 10.48 148.91 68.61 -40.42 4.62 -2.91 -61.86 -50.26 12.99 Cash after chg. in Working capital 335.37 525.41 511.81 519.51 258.48 256.39 192.25 146.65 232.16 188.91 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -237.56 -193.61 -182.99 -174.03 -145.01 -123.94 -208.26 -121.81 -148.99 -103.32 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.38 -3.03 -10.92 Cash From Investing Activity 35.12 -238.31 -249.64 -700.87 -88.77 102.66 625.87 277.52 57.14 -47.55 Net Fixed Assets -4.37 -97.28 -14.72 317.26 -1,183.17 -0.35 0.74 0.95 69.28 -16.41 Net Investments 1.39 1.39 1.40 6.15 1.83 1.50 1.56 1.40 -48.45 0.00 Others 38.10 -142.42 -236.32 -1,024.28 1,092.57 101.51 623.57 275.17 36.31 -31.14 Cash from Financing Activity -109.85 -110.35 -82.59 -61.88 -1.38 -1,360.17 -43.20 -14.13 -86.26 -43.32 Net Cash Inflow / Outflow 23.08 -16.86 -3.41 -417.27 23.32 -1,125.06 566.66 287.85 51.01 -16.20 Opening Cash & Equivalents 50.73 67.59 71.05 488.40 307.86 1,432.92 866.26 578.42 527.40 543.02 Closing Cash & Equivalent 73.81 50.73 67.59 71.05 488.40 307.86 1,432.92 866.26 578.42 527.40

Description Nov 08 Nov 07 Nov 06 Nov 05
Cash From Operating Activity 237.76 16.63 123.19 102.74 PBT 211.22 468.69 186.01 135.23 Adjustment -49.50 -298.40 -8.73 7.24 Changes in Working Capital -7.89 -33.39 11.64 -2.41 Cash after chg. in Working capital 153.83 136.91 188.92 140.06 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -126.90 -113.33 -65.74 -37.32 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity -78.87 232.35 -47.99 -73.08 Net Fixed Assets -20.35 17.89 2.55 Net Investments 0.00 -0.50 0.00 Others -58.52 214.96 -50.54 Cash from Financing Activity -95.20 -75.90 -33.82 -46.02 Net Cash Inflow / Outflow 63.69 173.09 41.38 -16.36 Opening Cash & Equivalents 479.91 306.83 10.00 26.36 Closing Cash & Equivalent 543.61 479.91 51.38 10.00

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Nov 09
Book Value (Rs.) 658.22 586.49 528.72 472.92 431.28 220.64 567.81 437.21 389.88 333.21 ROA 11.25% 10.36% 10.95% 11.22% 4.00% 14.91% 28.24% 12.75% 13.40% 7.15% ROE 15.07% 14.11% 14.70% 14.75% 5.31% 18.77% 33.56% 14.96% 20.98% 14.46% ROCE 23.22% 21.49% 22.62% 22.78% 15.87% 28.96% 46.38% 22.66% 32.17% 22.18% Fixed Asset Turnover 1.90 1.91 2.08 1.85 2.75 10.04 9.32 9.63 8.50 5.12 Receivable days 28.62 24.43 22.58 26.35 31.59 49.42 47.27 38.93 23.14 26.99 Inventory Days 59.95 57.05 61.01 65.25 51.10 49.61 58.01 55.11 38.34 51.76 Payable days 115.62 121.93 93.70 92.76 62.95 78.13 72.79 55.37 45.61 74.57 Cash Conversion Cycle -27.05 -40.45 -10.12 -1.16 19.73 20.89 32.50 38.68 15.87 4.18 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 384.67 712.57 264.69 337.93 138.46 310.56 401.51 134.63 140.75 0.00

Description Nov 08 Nov 07 Nov 06 Nov 05
Book Value (Rs.) 301.96 216.74 142.90 113.68 ROA 18.37% 26.37% 10.07% 9.39% ROE 38.71% 63.36% 27.78% 22.90% ROCE 54.15% 84.11% 42.50% 35.52% Fixed Asset Turnover 5.62 5.16 4.71 4.43 Receivable days 28.15 30.12 35.19 39.05 Inventory Days 50.96 44.60 43.53 41.49 Payable days 69.16 84.39 92.33 80.44 Cash Conversion Cycle 9.95 -9.68 -13.61 0.09 Total Debt/Equity 0.00 0.00 0.00 0.00 Interest Cover 0.00 0.00 2275.76 712.58

Top Investors:

aditya birla sun life trustee private limited a/c aditya birla sun life pharma & healthcare fund

life insurance corporation of india

qualfied institutional buyer

bajaj allianz life insurance company ltd

Annual Reports:

News Update:

Pfizer’s parent company identifies some antiviral compounds to inhibit coronavirus: Report
3rd Mar 2020, 11:54 AM

The company is engaging with a third party to screen the compounds
Read More
Pfizer - Quarterly Results
14th Feb 2020, 14:09 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback